D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 74 Citations 18,466 327 World Ranking 448 National Ranking 12

Overview

What is he best known for?

The fields of study he is best known for:

  • Antibiotics
  • Bacteria
  • Internal medicine

George G. Zhanel spends much of his time researching Microbiology, Antibacterial agent, Pharmacology, Antibiotics and Drug resistance. His research integrates issues of Klebsiella pneumoniae and Escherichia coli in his study of Microbiology. His Antibacterial agent research integrates issues from Ciprofloxacin, Vancomycin and Tigecycline.

His Pharmacology study combines topics from a wide range of disciplines, such as Minimum inhibitory concentration, Anaerobic bacteria and Gatifloxacin. His research investigates the connection with Antibiotics and areas like Bacteria which intersect with concerns in Anti-Infective Agents, Combinatorial chemistry and Drug development. His studies deal with areas such as Glycylcycline and Antimicrobial as well as Drug resistance.

His most cited work include:

  • Comparative review of the carbapenems. (394 citations)
  • A Critical Review of the Fluoroquinolones (280 citations)
  • A Critical Review of the Fluoroquinolones (280 citations)

What are the main themes of his work throughout his whole career to date?

His main research concerns Microbiology, Antibiotics, Antibacterial agent, Streptococcus pneumoniae and Antimicrobial. His work carried out in the field of Microbiology brings together such families of science as Pseudomonas aeruginosa and Escherichia coli. George G. Zhanel has researched Antibiotics in several fields, including Efflux, Internal medicine, Pharmacology and Bacteria.

His Antibacterial agent study incorporates themes from Vancomycin, Minimum inhibitory concentration and Aminoglycoside. His Streptococcus pneumoniae research incorporates elements of Penicillin, Streptococcaceae and Serotype, Virology. The study incorporates disciplines such as Trimethoprim and Levofloxacin in addition to Ciprofloxacin.

He most often published in these fields:

  • Microbiology (65.51%)
  • Antibiotics (22.92%)
  • Antibacterial agent (21.76%)

What were the highlights of his more recent work (between 2015-2021)?

  • Microbiology (65.51%)
  • Antimicrobial (16.67%)
  • Antibiotics (22.92%)

In recent papers he was focusing on the following fields of study:

Microbiology, Antimicrobial, Antibiotics, Pseudomonas aeruginosa and Antibiotic resistance are his primary areas of study. His research on Microbiology often connects related areas such as Efflux. George G. Zhanel has researched Antimicrobial in several fields, including Clostridium difficile, Ciprofloxacin, Fidaxomicin, Streptococcus pneumoniae and Diarrhea.

His research in Antibiotics intersects with topics in Adjuvant, Pharmacology, Acinetobacter baumannii and Bacteria. His Pseudomonas aeruginosa study also includes

  • Colistin and related Ceftolozane, Tazobactam and Minimum inhibitory concentration,
  • Meropenem, which have a strong connection to Imipenem. His work carried out in the field of Antibiotic resistance brings together such families of science as Enterobacteriaceae and Intensive care medicine.

Between 2015 and 2021, his most popular works were:

  • Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations. (132 citations)
  • Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent (111 citations)
  • Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent (111 citations)

In his most recent research, the most cited papers focused on:

  • Antibiotics
  • Bacteria
  • Internal medicine

The scientist’s investigation covers issues in Microbiology, Pharmacology, Antibiotics, Pseudomonas aeruginosa and Antibiotic resistance. His Microbiology research integrates issues from Efflux and Acinetobacter baumannii. His Pharmacology research includes themes of Ciprofloxacin, Tigecycline, Eravacycline, Meropenem and Avibactam.

George G. Zhanel combines subjects such as Dermatology, Vancomycin and Bacteria with his study of Antibiotics. His research integrates issues of Antibiotic exposure and Multiple drug resistance in his study of Antibiotic resistance. His work deals with themes such as Internal medicine and Enterobacteriaceae, which intersect with Antimicrobial.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Comparative review of the carbapenems.

George G Zhanel;Ryan Wiebe;Leanne Dilay;Kristjan Thomson.
Drugs (2007)

649 Citations

A Critical Review of the Fluoroquinolones

George G. Zhanel;George G. Zhanel;Kelly Ennis;Lavern Vercaigne;Andrew Walkty.
Drugs (2002)

429 Citations

Epidemic Clonal Groups of Escherichia coli as a Cause of Antimicrobial-Resistant Urinary Tract Infections in Canada, 2002 to 2004

James R. Johnson;James R. Johnson;Megan Menard;Megan Menard;Brian Johnston;Brian Johnston;Michael A. Kuskowski;Michael A. Kuskowski.
Antimicrobial Agents and Chemotherapy (2009)

369 Citations

Fluoroquinolone-Associated Tendinopathy: A Critical Review of the Literature

Yasmin Khaliq;George G. Zhanel.
Clinical Infectious Diseases (2003)

362 Citations

Clinical Practice Guidelines for Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia in Adults

Coleman Rotstein;Gerald Evans;Abraham Born;Ronald Grossman.
Canadian Journal of Infectious Diseases & Medical Microbiology (2008)

362 Citations

Review of macrolides and ketolides: focus on respiratory tract infections.

George G. Zhanel;Maria Dueck;Daryl J. Hoban;Lavern M. Vercaigne.
Drugs (2001)

355 Citations

The glycylcyclines: a comparative review with the tetracyclines.

George G Zhanel;Kristen Homenuik;Kim Nichol;Ayman Noreddin.
Drugs (2004)

353 Citations

Ceftazidime-avibactam: a novel cephalosporin/β-lactamase inhibitor combination.

George G. Zhanel;George G. Zhanel;Christopher D. Lawson;Heather Adam;Heather Adam;Frank Schweizer.
Drugs (2013)

349 Citations

Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines.

Joseph P Lynch;George G Zhanel.
Current Opinion in Pulmonary Medicine (2010)

337 Citations

Antibiotic resistance in Escherichia coli outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA).

George G. Zhanel;Tamiko L. Hisanaga;Nancy M. Laing;Melanie R. DeCorby.
International Journal of Antimicrobial Agents (2006)

321 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing George G. Zhanel

James R. Johnson

James R. Johnson

University of Minnesota

Publications: 138

David P. Nicolau

David P. Nicolau

Hartford Hospital

Publications: 97

Ronald N. Jones

Ronald N. Jones

JMI Laboratories

Publications: 90

Helio S. Sader

Helio S. Sader

JMI Laboratories

Publications: 83

Robert K. Flamm

Robert K. Flamm

Janssen (Belgium)

Publications: 82

Brian D. Johnston

Brian D. Johnston

University of Minnesota

Publications: 72

Michael J. Rybak

Michael J. Rybak

Eugene Applebaum College of Pharmacy and Health Sciences

Publications: 57

Matteo Bassetti

Matteo Bassetti

University of Genoa

Publications: 54

Rodrigo E. Mendes

Rodrigo E. Mendes

JMI Laboratories

Publications: 52

Jeffrey Lipman

Jeffrey Lipman

Royal Brisbane and Women's Hospital

Publications: 51

David L. Paterson

David L. Paterson

University of Queensland

Publications: 50

Mariana Castanheira

Mariana Castanheira

JMI Laboratories

Publications: 43

Jason A. Roberts

Jason A. Roberts

Royal Brisbane and Women's Hospital

Publications: 43

Connie Clabots

Connie Clabots

VA Midwest Health Care Network

Publications: 41

Donald E. Low

Donald E. Low

University of Toronto

Publications: 41

Matthew E. Falagas

Matthew E. Falagas

Alfa Institute of Biomedical Sciences

Publications: 39

Trending Scientists

Ran Tao

Ran Tao

Beijing Institute of Technology

Daniel Alpay

Daniel Alpay

Chapman University

Aart W. Kleyn

Aart W. Kleyn

Leiden University

Woo Jin Kim

Woo Jin Kim

Hongik University

Xiao-Tao Lü

Xiao-Tao Lü

Chinese Academy of Sciences

Richard J. Haynes

Richard J. Haynes

University of Queensland

David L. Burton

David L. Burton

Dalhousie University

Peter E. Urwin

Peter E. Urwin

University of Leeds

Neil C. Chi

Neil C. Chi

University of California, San Diego

Egon T. Degens

Egon T. Degens

Universität Hamburg

Andrew J. S. McGonigle

Andrew J. S. McGonigle

University of Sheffield

Koen Hufkens

Koen Hufkens

Ghent University

Harry A. Taylor

Harry A. Taylor

Goddard Space Flight Center

Maria Larsson

Maria Larsson

Stockholm University

Susan P. Keane

Susan P. Keane

University of North Carolina at Greensboro

Stefano Nava

Stefano Nava

University of Bologna

Something went wrong. Please try again later.